5556-24-1 Usage
General Description
3-Hydroxythiophene-2,5-dicarboxylic acid dimethyl ester is a chemical compound that belongs to the family of thiophene derivatives. It is a dimethyl ester of the 3-Hydroxythiophene-2,5-dicarboxylic acid, which is a white solid with a molecular formula of C10H8O5S. 3-Hydroxythiophene-2,5-dicarboxylic acid dimethyl ester has various industrial applications and is commonly used in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is also used as an intermediate in the production of organic compounds and for research purposes in the field of organic chemistry. 3-Hydroxythiophene-2,5-dicarboxylic acid dimethyl ester is considered to be a valuable building block in organic synthesis due to its unique structure and versatile reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 5556-24-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,5 and 6 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5556-24:
(6*5)+(5*5)+(4*5)+(3*6)+(2*2)+(1*4)=101
101 % 10 = 1
So 5556-24-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H8O5S/c1-12-7(10)5-3-4(9)6(14-5)8(11)13-2/h3,11H,1-2H3/b8-6+
5556-24-1Relevant articles and documents
Efficient synthesis of 3,6-dialkoxythieno[3,2-b]thiophenes as precursors of electrogenerated conjugated polymers
Hergue, Noemie,Frere, Pierre,Roncali, Jean
, p. 588 - 595 (2011)
A series of 3,6-dialkoxythieno[3,2-b]thiophenes have been synthesized through three synthetic pathways. Symmetrical derivatives have been obtained from 3,6-dibromothieno[3,2-b]thiophene or by trans-etherification of 3,6-dimethoxythieno[3,2-b]thiophene while unsymmetrical derivatives have been easily prepared from the readily accessible dimethyl 3-hydroxythiophene-2,5- dicarboxylate. These compounds have been used as precursors for electropolymerisation and a first characterisation of the electronic properties of the resulting polymers is presented.
CYCLIC COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 177-178, (2021/06/11)
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acc
